Riskpilot← Back to searchSign inGet full accessEspergærde Dyreklinik ApS
APSActiveCVR 37837466Fredensvej 14Veterinary activities · NACE 7500Est. 201611 employees
Revenue 2024
DKK 6,1M
+11% vs 2023
EBITDA margin
32.6%
+40% vs 2023
Equity ratio
64.5%
Financial strength
Net profit 2024
DKK 1,4M
+52% vs 2023
| Revenue | DKK 6,1M | +11% |
| EBITDA | DKK 2M | +40% |
| Net profit | DKK 1,4M | +52% |
| Total assets | DKK 3,3M | +22% |
| Equity | DKK 2,1M | +21% |
| Employees | 11 | — |
Legal name
Espergærde Dyreklinik ApS
CVR number
37837466
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
26. juni 2016
Share capital
DKK 300.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af den samlede direktion.
Company purpose
Virksomhedens formål er at drive dyreklinik.
Address
Fredensvej 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5.114 | 5.135 | 5.380 | 5.532 | 6.125 |
| Staff expenses | -4.549 | -3.503 | -3.656 | -4.105 | -4.128 |
| EBITDA | 565 | 1.632 | 1.723 | 1.427 | 1.996 |
| Depreciation & amort. | -235 | -254 | -269 | -268 | -240 |
| EBIT | 330 | 1.378 | 1.454 | 1.160 | 1.756 |
| Net financials | -6 | -4 | -8 | 0 | 4 |
| Profit before tax | 324 | 1.374 | 1.446 | 1.160 | 1.761 |
| Tax | 72 | 304 | 320 | 259 | 393 |
| Net profit | 252 | 1.070 | 1.126 | 900 | 1.367 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4.029 | 2.687 | 2.714 | 2.737 | 3.330 |
| Equity | 1.434 | 1.754 | 1.880 | 1.780 | 2.147 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.410 | 779 | 721 | 887 | 1.153 |
| Total debt | 2.410 | 779 | 721 | 887 | 1.153 |
EBITDA margin
32.6%
This company
15.8%
Market median
+106% vs market
20202024
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
20202024
Return on equity
63.7%
This company
18.4%
Market median
+246% vs market
20202024
Net profit margin
22.3%
This company
8.1%
Market median
+175% vs market
20202024
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20202024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NJ Founder | Founder | 2016 |
SL Management | Management | 2018 |
| Former (1) | ||
AD Management | Management | 2018 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 66.67–89.99% | 2023 | |
| Company | 25–33.32% | 25–33.32% | 2023 | |
| Company | 20–24.99% | 20–24.99% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
N.J.J. Holding ApS
Espergærde Dyreklinik ApS Board members of Espergærde Dyreklinik ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Jacob Jensen | Founder | 0 companies |
| Anne Dorthe Skøttrup Broe | Management | 0 companies |
| Stine Laursen | Management | 0 companies |